INTENSIVE REVIEW of NEPHROLOGY 2023 TOPICS
1. Renal Physiology for the Boards – Melanie P. Hoenig, MD
2. Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD
3. Question and Answer Session – Faculty
4. Renal Pathology in 2022 – Part 1 Nephritic Condition – Helmut G. Rennke, MD
5. Renal Pathology in 2022 – Part 2 – Astrid Weins, MD, PhD
6. Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MB BCh
7. Question and Answer Session – Faculty
8. IgA Nephropathy – Gerald B. Appel, MD
9. Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
10. ANCA Vasculitis – John L. Niles, MD
11. Question and Answer Session – Faculty
12. Update on Lupus Nephritis – Gerald B. Appel, MD
13. Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
14. Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
15. Question and Answer Session – Faculty
16. Hyponatremia and Hypernatremia – Sodium Disorders – David B. Mount, MD
17. Hypokalemia and Hyperkalemia – Potassium Disorders – David B. Mount, MD
18. Question and Answer Session – Faculty
19. Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir
20. Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, BChir
21. Question and Answer Session – Faculty
22. Treating Renal Patients with Rituximab in the Era of Covid-19 – David B. Mount, MD
23. Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
24. Update on Polycystic Kidney Disease – Cristian Riella, MD
25. Question and Answer Session – Faculty
26. Pediatric Nephrology – Michael J.G. Somers, MD
27. Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD
28. Health Disparities in Chronic Kidney Disease – Lupus Nephritis as a Model Social Determinants, Biology, and Unmet Needs – Winfred W. Williams, Jr., MD
29. SPECIAL LECTURE — Pig-to-Human Xenotransplantation: NYU Langone Health’s Experience – Robert Montgomery, MD, PhD
30. Why Do We Reject a Transplant? – Jamil R. Azzi, MD
31. Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
32. Question and Answer Session – Faculty
33. Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
34. Early Post-Transplant Management – Anil K. Chandraker, MD
35. Question and Answer Session – Faculty
36. Evaluation of the Kidney Living Donor – Kassem Safa, MD
37. Late Loss of the Kidney Transplant – Andrew S. Allegretti, MD, MSc
38. Infections in Transplant Recipients – Sarah P. Hammond, MD
39. Monitoring Kidney Transplant Patients: Beyond Creatinine – Saif Abdulkarim Muhsin, MB BCh
40. Pre-Transplant Surgical Evaluation of Recipients – Jamil R. Azzi, MD
41. Question and Answer Session – Faculty
42. Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD
43. Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
44. Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD
45. Geriatric Nephrology – Ernest I. Mandel, MD
46. Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh
47. Management of Hypertension after SPRINT – A Plethora of Guidelines – Richard J. Glassock, MD
48. Question and Answer Session – Faculty
49. Secondary Hypertension – Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
50. Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
51. Liver and the Kidney – Andrew S. Allegretti, MD, MSc
52. Question and Answer Session – Faculty
53. Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
53. Acute Kidney Injury Syndromes – Alice M. Sheridan, MD
55. ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
56. Question and Answer Session – Faculty
57. Cancer and Acute Kidney Injury – Albert Q. Lam, MD
58. Paraprotein-Induced Kidney Injury – Albert Q. Lam, MD
59. Focal and Segmental Glomerulosclerosis (FSGS): A Lesion, Not a Disease – Richard J. Glassock, MD
60. From Genes to Therapies – Anna Greka, MD, PhD
61. APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD
62. Question and Answer Session – Faculty
63. Dialysis Dosing – J. Kevin Tucker, MD
64. Mineral and Bone Disease – David Bushinsky, MD
65. Question and Answer Session – Faculty
66. Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
67. Pearls in Mineral and Bone Disease – David Bushinsky, MD
68. Chronic Kidney Disease Epidemiology – A 2022 Update – Gearoid M. McMahon, MB BCh
69. Question and Answer Session – Faculty
70. Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
71. Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC
72. Peritoneal Dialysis: Audience Questions Answered – J. Kevin Tucker, MD
73. Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD, MPH
74. Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD
75. Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
76. Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD
77. Question and Answer Session – Faculty
78. Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD
79. Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA
80. Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, BChir
81. Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, BChir
82. Chronic Kidney Disease in the Community – Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP
83. COVID-19 Vaccination Response in Transplant Patients – Ann E. Woolley, MD
84. Update on Renovascular Disease – Joseph M. Garasic, MD
85. Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS
86. Immunologic Basis of Kidney Disease – Vivek Kasinath, MD
87. Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD
88. Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH
89. Ethics in Nephrology – Valerie Luyckx, MD, MB BCh
90. Pregnancy and Renal Disease – Jessica Tangren, MD
91. Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD, and Edgar L. Milford, Jr., MD
92. Transplant Board Review – Anil K. Chandraker, MD
93. Must-Know Board Zebras – Emily S. Robinson, MD, MPH
94. Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI
95. Nephrology Board Review Practice 2 – Mallika Mendu, MD, MBA